Krishna Institute of Medical Sciences Ltd's Q4FY25 Quarter Results
- 13 May 2025
Result Summary
- Krishna Institute of Medical Sciences Ltd reported a 19.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.8%.
- Its expenses for the quarter were down by 18.0% QoQ and up 18.5% YoY.
- The net profit decreased 22.7% QoQ and decreased 27.5% YoY.
- The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 8.2 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 637.60 | 790.20 | 580.81 | -19.3% | 9.8% |
Total Expenses | 537.49 | 655.60 | 453.55 | -18.0% | 18.5% |
Profit Before Tax | 100.12 | 134.60 | 127.27 | -25.6% | -21.3% |
Tax | 28.50 | 42.10 | 28.60 | -32.3% | -0.3% |
Profit After Tax | 71.49 | 92.50 | 98.67 | -22.7% | -27.5% |
Earnings Per Share | 8.20 | 2.20 | 11.70 | 272.7% | -29.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Krishna Institute of Medical Sciences Ltd (KIMS) is a prominent healthcare provider in India, primarily engaged in offering a range of medical services. The company operates a network of hospitals that provide healthcare services, including specialties such as cardiology, neurology, orthopedics, and oncology. KIMS has been recognized for its quality care and advanced medical facilities, positioning itself as a key player in the healthcare industry. However, specific recent developments within the company are not available in the provided data, and further external research would be required for a comprehensive understanding of its current strategic direction or operational changes.
Revenue
In the fourth quarter of fiscal year 2025 (Q4FY25), Krishna Institute of Medical Sciences Ltd reported total income of ₹637.60 crores. This represents a decrease of 19.3% from the third quarter of fiscal year 2025 (Q3FY25), where the company achieved a total income of ₹790.20 crores. However, when compared year-over-year, there was an increase of 9.8% from Q4FY24, where total income stood at ₹580.81 crores. These figures highlight a quarter-over-quarter decline in revenue, while showcasing a year-over-year growth in total income. The fluctuations in quarterly income could be reflective of seasonal trends or other operational factors impacting revenue generation.
Profitability
Krishna Institute of Medical Sciences Ltd reported a profit before tax (PBT) of ₹100.12 crores in Q4FY25, which is a 25.6% decrease from ₹134.60 crores reported in Q3FY25. Compared to the same quarter in the previous year (Q4FY24), where the PBT was ₹127.27 crores, there is a year-over-year decline of 21.3%. The profit after tax (PAT) for Q4FY25 was ₹71.49 crores, showing a quarter-over-quarter decrease of 22.7% from Q3FY25's PAT of ₹92.50 crores, and a year-over-year decrease of 27.5% from Q4FY24's PAT of ₹98.67 crores. The company's earnings per share (EPS) for Q4FY25 was ₹8.20, which, despite showing a significant quarter-over-quarter increase of 272.7% from Q3FY25's EPS of ₹2.20, represents a year-over-year decline of 29.9% from Q4FY24's EPS of ₹11.70.
Operating Metrics
In Q4FY25, total expenses for Krishna Institute of Medical Sciences Ltd were reported at ₹537.49 crores, reflecting an 18.0% decrease from the previous quarter's expenses of ₹655.60 crores. Year-over-year, the expenses increased by 18.5% from ₹453.55 crores in Q4FY24. The tax expense for Q4FY25 was ₹28.50 crores, marking a 32.3% decrease from the previous quarter's tax of ₹42.10 crores, and a slight year-over-year decrease of 0.3% from ₹28.60 crores in Q4FY24. These financial metrics indicate changes in the operational cost structure and tax liabilities, which could be associated with the company's financial strategies or external economic factors. Further analysis of these metrics in conjunction with revenue and profitability data can provide deeper insights into the company's operational efficiency and financial health.